Clinical Trial Update: A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial update of LY3209590 in healthy participants and people with Type 2 diabetes, sponsored by Eli Lilly; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3209590 (LY3209590)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED